April 27, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the selection of oral contrast agent and optimization of bowel preparation for oncologic computed tomography (CT) could help avoid potentially severe clinical consequences of missed malignant deposits.

April 27, 2022 — Having dense breasts (more fibroglandular tissue than fatty tissue, as visualized on a mammogram) reduces the sensitivity of mammography by masking breast cancers and carries a 1.6- to 2.0-fold increased independent risk for breast cancer. To inform women about these risks, 38 U.S.


The Software & Information Industry Association (SIIA) announced winners for the 68th Jesse H. Neal Awards – one of the longest running premier awards programs honoring business-to-business (B2B) journalism. Imaging Technology News (ITN) is honored to have won this prestigious award in both of its nominated categories.

ITN took the top honors for:


April 26, 2022 — A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used in patients with brain metastasis to detect radioresistance.

ESMO Breast Cancer Congress 2022

April 26, 2022 — The companies conducted a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed for improved pulmonary nodule detection. The software was deployed in two major primary care centers in Lithuania.

April 26, 2022 — The American College of Radiology (ACR) Economics and Health Policy Department today announced Robert Zeman, MD, FACR, FSAR, as the 2022 recipient of the William T. Thorwarth Jr., MD, Award at ACR 2022, the College’s annual meeting in Washington, DC.

April 26, 2022 — The American College of Radiology Foundation (ACRF) presented its 2022 Global Humanitarian Award today at ACR 2022, the College’s annual meeting in Washington, DC. The Global Humanitarian Award honors individuals who have had a positive global impact on radiology services.

April 25, 2022 — Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer.

April 25, 2022 — Fostering global excellence in diagnostic accuracy, DetectedX and GE Healthcare have entered into an educational partnership to expand access to the

Subscribe Now